• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《欧洲老年人中 EQ-5D-3L 的可行性和有效性:利用 SHARE(d) 数据进行的二次数据分析》

Feasibility and validity of the EQ-5D-3L in the elderly Europeans: a secondary data analysis using SHARE(d) data.

机构信息

EuroQol Group, Rotterdam, The Netherlands.

Department of Health Economics and Health Care Management, Bielefeld University, 33615, Bielefeld, Germany.

出版信息

Qual Life Res. 2022 Nov;31(11):3267-3282. doi: 10.1007/s11136-022-03158-3. Epub 2022 May 27.

DOI:10.1007/s11136-022-03158-3
PMID:35624409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9546963/
Abstract

PURPOSE

To determine feasibility and validity of the EQ-5D-3L in the elderly European population.

METHODS

Secondary data analysis based on the study of health, ageing, and retirement in Europe (SHARE) to determine the percentage of missing items for EQ-5D dimensions and EQ VAS, and to demonstrate convergent/divergent validity with measures included in the SHARE survey. Known-groups validity was tested using literature-based hypotheses. Correlation coefficients and Cohen's f are reported.

RESULTS

Missing values were below 3% across all EQ-5D dimensions and gender strata, slightly increasing with age. Individuals' responses to each EQ-5D dimension were related to their ratings of other measures in expected directions. The EQ VAS and all EQ-5D dimensions (except anxiety/depression) moderately to strongly correlated with physical [e.g. number of limitations in activities of daily living (ADL): r = 0.313-0.658] and generic measures [CASP (control, autonomy, self-realization, pleasure)-19 scale, self-perceived health, number of symptoms: r = 0.318-0.622], while anxiety/depression strongly correlated with the EURO-D scale (r = 0.527). Both EQ-5D dimensions and EQ VAS discriminated well between two [or more] groups known to differ [e.g. anxiety/depression discriminated well between persons classified as depressed/not depressed using the EURO-D scale, f = 0.51; self-care differentiated best between individuals without and with 1 + ADL limitations, f = 0.69]. Sociodemographic variables like gender, education, and partner in household were hardly associated with EQ VAS scores (f < 0.25).

CONCLUSION

With item non-response of less than 3%, good discriminatory, and construct properties, the EQ-5D-3L showed to be a feasible and valid measure in the elderly Europeans.

摘要

目的

确定 EQ-5D-3L 在欧洲老年人中的可行性和有效性。

方法

基于健康、老龄化和退休研究(SHARE)的二次数据分析,确定 EQ-5D 维度和 EQ VAS 的缺失项目百分比,并展示与 SHARE 调查中包含的措施的收敛/发散有效性。使用基于文献的假设测试了已知组的有效性。报告相关系数和 Cohen's f。

结果

所有 EQ-5D 维度和性别分层的缺失值均低于 3%,略随年龄增加而增加。个体对每个 EQ-5D 维度的反应与其对其他措施的评分呈预期方向相关。EQ VAS 和所有 EQ-5D 维度(焦虑/抑郁除外)与身体相关[例如日常生活活动(ADL)的限制数量:r=0.313-0.658]和通用措施[CASP(控制、自主、自我实现、愉悦)-19 量表、自我感知健康、症状数量:r=0.318-0.622]中度至高度相关,而焦虑/抑郁与 EURO-D 量表强烈相关(r=0.527)。EQ-5D 维度和 EQ VAS 很好地区分了已知差异的两个[或更多]组[例如,使用 EURO-D 量表,焦虑/抑郁很好地区分了抑郁/不抑郁的人群,f=0.51;自我护理在无 ADL 限制和 1+ADL 限制的个体之间区分最佳,f=0.69]。性别、教育和家庭伴侣等社会人口变量与 EQ VAS 评分几乎没有关联(f<0.25)。

结论

EQ-5D-3L 具有小于 3%的项目无应答率、良好的区分度和结构特性,表明在欧洲老年人中是一种可行和有效的测量工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/9546963/1e88e62afb0b/11136_2022_3158_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/9546963/4f623f07935a/11136_2022_3158_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/9546963/9d611854f352/11136_2022_3158_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/9546963/1e88e62afb0b/11136_2022_3158_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/9546963/4f623f07935a/11136_2022_3158_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/9546963/9d611854f352/11136_2022_3158_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d93/9546963/1e88e62afb0b/11136_2022_3158_Fig3_HTML.jpg

相似文献

1
Feasibility and validity of the EQ-5D-3L in the elderly Europeans: a secondary data analysis using SHARE(d) data.《欧洲老年人中 EQ-5D-3L 的可行性和有效性:利用 SHARE(d) 数据进行的二次数据分析》
Qual Life Res. 2022 Nov;31(11):3267-3282. doi: 10.1007/s11136-022-03158-3. Epub 2022 May 27.
2
Validity, reliability, and feasibility of EQ-5D-3L, VAS, and time trade-off among Jordanians.EQ-5D-3L、视觉模拟量表(VAS)以及时间权衡法在约旦人群中的效度、信度和可行性。
J Healthc Qual Res. 2025 Jan-Feb;40(1):29-38. doi: 10.1016/j.jhqr.2024.10.001. Epub 2024 Nov 27.
3
Statistical Groupings of Mental Health and Osteoarthritis Severity Correlate With 10-year Trajectories of Levels of Capability and Comfort Among People With Hip Pain: A Nationwide Prospective Cohort Study (CHECK).心理健康与骨关节炎严重程度的统计分组与髋部疼痛患者10年能力和舒适度轨迹相关:一项全国性前瞻性队列研究(CHECK)。
Clin Orthop Relat Res. 2025 Jul 16. doi: 10.1097/CORR.0000000000003612.
4
Assessing the psychometric properties of generic (EQ-5D-5L) and disease-specific (KCCQ) quality of life in patients with hypertrophic cardiomyopathy in the AFFECT-HCM study.在AFFECT-HCM研究中评估肥厚型心肌病患者的通用(EQ-5D-5L)和疾病特异性(KCCQ)生活质量的心理测量特性。
Open Heart. 2025 May 27;12(1):e003143. doi: 10.1136/openhrt-2024-003143.
5
Construct validity of EQ-5D-5L among patients with inflammatory bowel disease-a study based on real-world data from the Swedish Inflammatory Bowel Disease Registry.炎症性肠病患者 EQ-5D-5L 的结构效度——基于瑞典炎症性肠病登记处真实世界数据的研究。
J Patient Rep Outcomes. 2024 Mar 27;8(1):39. doi: 10.1186/s41687-024-00709-9.
6
Aphasia-specific or generic outcomes? a comparison of two health-related quality of life instruments for economic evaluations of aphasia treatments.失语症特异性结果还是一般性结果?两种用于失语症治疗经济评估的健康相关生活质量工具的比较。
Qual Life Res. 2025 Jul 26. doi: 10.1007/s11136-025-04040-8.
7
Psychometric performance of the CFQ-R-8D compared to the EQ-5D-3L and SF-6D in people with cystic fibrosis.CFQ-R-8D 与 EQ-5D-3L 和 SF-6D 在囊性纤维化患者中的心理测量性能比较。
J Patient Rep Outcomes. 2024 Feb 28;8(1):24. doi: 10.1186/s41687-024-00697-w.
8
The Psychometric Performance of Generic Preference-Based Measures in Informal Carers: A Systematic Review of Validation Studies.通用偏好性测量工具在非正式照料者中的心理测量性能:验证研究的系统评价
Pharmacoeconomics. 2025 Jun 28. doi: 10.1007/s40273-025-01509-9.
9
Feasibility of the EQ-5D in the elderly population: a systematic review of the literature.老年人中 EQ-5D 的可行性:文献系统综述。
Qual Life Res. 2022 Jun;31(6):1621-1637. doi: 10.1007/s11136-021-03007-9. Epub 2021 Oct 6.
10
Health Status Outcomes After Computed Tomography or Invasive Coronary Angiography for Stable Chest Pain: A Prespecified Secondary Analysis of the DISCHARGE Randomized Clinical Trial.计算机断层扫描或有创冠状动脉造影检查后稳定型胸痛患者的健康状况结局:DISCHARGE随机临床试验的预设二次分析
JAMA Cardiol. 2025 May 14. doi: 10.1001/jamacardio.2025.0992.

引用本文的文献

1
Cognitive function in generally healthy adults age 70 years and older in the 5-country DO-HEALTH study: MMSE and MoCA scores by sex, education and country.五国DO-HEALTH研究中70岁及以上一般健康成年人的认知功能:按性别、教育程度和国家划分的MMSE和MoCA评分
Aging Clin Exp Res. 2025 Mar 17;37(1):88. doi: 10.1007/s40520-025-02946-4.
2
Factors associated with self-rated health in people with late-stage parkinson's and cognitive impairment.晚期帕金森病伴认知障碍患者自感健康状况的相关因素。
Qual Life Res. 2024 Sep;33(9):2439-2452. doi: 10.1007/s11136-024-03703-2. Epub 2024 Jun 18.
3
Drug-Drug Interactions and Their Association with Adverse Health Outcomes in the Older Community-Dwelling Population: A Prospective Cohort Study.

本文引用的文献

1
Feasibility of the EQ-5D in the elderly population: a systematic review of the literature.老年人中 EQ-5D 的可行性:文献系统综述。
Qual Life Res. 2022 Jun;31(6):1621-1637. doi: 10.1007/s11136-021-03007-9. Epub 2021 Oct 6.
2
Methods Used to Identify, Test, and Assess Impact on Preferences of Bolt-Ons: A Systematic Review.用于识别、测试和评估附加组件对偏好影响的方法:系统评价。
Value Health. 2021 Jun;24(6):901-916. doi: 10.1016/j.jval.2020.12.011. Epub 2021 Mar 18.
3
Comparison of the three-level and the five-level versions of the EQ-5D.
药物-药物相互作用及其与老年社区居民不良健康结局的关联:一项前瞻性队列研究。
Clin Drug Investig. 2024 Jun;44(6):439-453. doi: 10.1007/s40261-024-01369-9. Epub 2024 Jun 15.
4
Exploring differences and similarities of EQ-5D-3L, EQ-5D-5L and WHOQOL-OLD in recipients of aged care services in Germany.探讨德国老年护理服务接受者在 EQ-5D-3L、EQ-5D-5L 和 WHOQOL-OLD 方面的差异和相似之处。
PLoS One. 2023 Aug 25;18(8):e0290606. doi: 10.1371/journal.pone.0290606. eCollection 2023.
5
Increased patient satisfaction by integration of palliative care into geriatrics-A prospective cohort study.将姑息治疗整合到老年医学中以提高患者满意度-一项前瞻性队列研究。
PLoS One. 2023 Jun 22;18(6):e0287550. doi: 10.1371/journal.pone.0287550. eCollection 2023.
EQ-5D 的三等级版本与五等级版本的比较。
Eur J Health Econ. 2021 Jun;22(4):621-628. doi: 10.1007/s10198-021-01279-z. Epub 2021 Mar 18.
4
Psychometric properties of the EQ-5D-5L: a systematic review of the literature.EQ-5D-5L 的心理测量特性:文献系统综述。
Qual Life Res. 2021 Mar;30(3):647-673. doi: 10.1007/s11136-020-02688-y. Epub 2020 Dec 7.
5
Selecting Bolt-on Dimensions for the EQ-5D: Testing the Impact of Hearing, Sleep, Cognition, Energy, and Relationships on Preferences Using Pairwise Choices.选择 EQ-5D 的附加维度:使用配对选择测试听力、睡眠、认知、精力和人际关系对偏好的影响。
Med Decis Making. 2021 Jan;41(1):89-99. doi: 10.1177/0272989X20969686. Epub 2020 Nov 30.
6
Prevalence and incidence of cognitive impairment in an elder Portuguese population (65-85 years old).葡萄牙老年人群(65-85 岁)认知障碍的患病率和发生率。
BMC Geriatr. 2020 Nov 16;20(1):470. doi: 10.1186/s12877-020-01863-7.
7
Validity of the EQ-5D-5L questionnaire among the general population of Poland.波兰一般人群中 EQ-5D-5L 问卷的有效性。
Qual Life Res. 2021 Mar;30(3):817-829. doi: 10.1007/s11136-020-02667-3. Epub 2020 Oct 24.
8
EQ-5D-3L health status and health state utilities of the oldest-old (85 +) in Germany: results from the AgeCoDe-AgeQualiDe study.德国最年长人群(85 岁及以上)的 EQ-5D-3L 健康状况和健康状态效用:AgeCoDe-AgeQualiDe 研究结果。
Qual Life Res. 2020 Dec;29(12):3223-3232. doi: 10.1007/s11136-020-02597-0. Epub 2020 Aug 26.
9
Acceptability and Validity of the EQ-5D in Patients Living With Dementia.痴呆患者的 EQ-5D 的可接受性和有效性。
Value Health. 2020 Jun;23(6):760-767. doi: 10.1016/j.jval.2020.01.022. Epub 2020 May 22.
10
Mild cognitive impairment and quality of life in the oldest old: a closer look.轻度认知障碍与超高龄老人的生活质量:进一步观察。
Qual Life Res. 2020 Jun;29(6):1675-1683. doi: 10.1007/s11136-020-02425-5. Epub 2020 Jan 28.